Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/68gallium-arginine-glycine-aspartic-acid-and-18f-fluorodeoxyglucose-EsVwpDr0VT
References (8)
-
E Elisabeth Blom, I Velikyan, S Sergio Estrada (2012)
(68)Ga-Labeling of RGD peptides and biodistributionInt J Clin Exp Med, 5
-
N Quartuccio, G Treglia, M Salsano (2013)
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcomaRadiol Oncol, 47
-
JY Paik, BH Ko, YS Choe (2005)
PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activityNucl Med Biol, 32
-
AJ Beer, H Kessler, HJ Wester, M Schwaiger (2011)
PET imaging of integrin αvβ3 expressionTheranostics, 1
-
H Cai, PS Conti (2013)
RGD-based PET tracers for imaging receptor integrin αvβ3 expressionJ Labelled Comp Radiopharm, 56
-
HJ Im, TS Kim, SY Park (2012)
Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcomaEur J Nucl Med Mol Imaging, 39
-
MW Pedersen, S Holm, EL Lund (2001)
Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitroNeoplasia, 3
-
W Cheng, Z Wu, S Liang (2014)
Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancerPLoS One, 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2016 by Korean Society of Nuclear Medicine
- Subject
- Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
- ISSN
- 1869-3474
- eISSN
- 1869-3482
- DOI
- 10.1007/s13139-016-0400-6
- Publisher site
- See Article on Publisher Site
Abstract
We report the case of a 32 year-old male with Chondroblastic Osteosarcoma of the skull, which was imaged with both 18[F]fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and 68Gallium-arginine-glycine-aspartic acid (68Ga-RGD) PET/CT. The 18F-FDG PET/CT did not demonstrate the tumour, whereas the 68Ga-RGD PET/CT clearly depicted a left-sided frontal tumour. 68Ga-RGD PET/CT may be a clinically useful imaging modality for early detection of recurrent osteosarcoma, considering the limitations of 18F-FDG PET in a setting of low glycolytic activity.
Journal
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Feb 12, 2016